Cognitive Impairment in Early MS Not Linked to Ethnicity, US Study Suggests

Cognitive Impairment in Early MS Not Linked to Ethnicity, US Study Suggests
5
(1)

Ethnicity does not seem to have an influence on the degree of cognitive impairment seen in patients at the early stages of multiple sclerosis (MS), a U.S.-based study suggests.

The study, “Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis,” was published in the journal Neurology.

Most people with MS experience both physical and cognitive disability caused by chronic inflammation in the central nervous system, comprised of the brain and spinal cord.

Changes in cognitive function seen in the early stages of MS are known to help predict severe impairments in cognition later in the disease course. But researchers are still looking for factors that can help predict which patients are at higher risk for developing serious cognitive impairments.

It is believed that ethnicity plays a role in MS susceptibility rates.

Now, researchers at the University of Southern California, Keck School of Medicine, investigated whether a person’s ethnicity is a contributing factor for early changes in cognition.

To evaluate cognitive function, the team used the Symbol Digit Modalities Test (SDMT), a reliable tool used in MS and other neurological diseases. The test measures attention, processing speed, and working memory capacity, and can be used to evaluate changes in cognition over time.

The researchers used the oral version of the SDMT so as to exclude the effect of potential hand impairments in patients.

Participants were recruited from the MS Sunshine Study — a multi-ethnic, matched, case-control study of MS in southern California that analyzed the influence of vitamin D levels in disease incidence. For each patient, at least one healthy individual (control) with matched race/ethnicity, sex, and age was recruited.

Ultimately, data were collected from 1,174 adults, among whom 519 were white, 261 black, and 394 Hispanic. The Hispanic participants were mostly Mexican (78.9%) or of mixed-Mexican descent (3.4%), while most black participants were African-Americans born in the U.S. (97.2%). The majority of MS patients in the overall group were women (71%), with a mean age of 40.7 years at the time of the cognitive assessment.

Among white participants with MS, 64% had an annual income above the Californian median ($65,000), compared with 43% of black patients, and 44% of Hispanics. Compared with white and Hispanic patients, fewer black participants with MS completed college.

The SDMT results showed that MS patients had lower scores among all ethnic groups compared with controls. Those patients with black and Hispanic ethnicity had a lower mean SDMT — 47.3 and 53 — compared with white patients, with a score of 54.

Yet, the analysis showed that the relation between ethnicity and having MS on SDMT scores was not significant. Further analysis showed that MS patients of Hispanic or black ethnicity have a similar reduction in SDMT scores as the healthy controls.

“We did not find any evidence that MS causes more cognitive impairment in black or Hispanic patients early in the disease course compared to white patients,” the researchers said.

This finding suggests that differences in cognitive impairment among people with MS is most likely due to differences found in the underlying population.

“Lower absolute SDMT scores among black and Hispanic patients compared to white patients highlight underlying U.S. population differences rather than differences in MS disease severity,” the researchers said.

Newly diagnosed MS patients “are more likely to have subtly impaired cognitive function than controls regardless of race/ethnicity,” the team concluded.

The researchers suggested that “improving opportunities for higher educational attainment and higher incomes for black and Hispanic participants in the United States would likely reduce racial/ethnic disparities in cognitive performance.”

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Total Posts: 1,053
Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
×
Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Latest Posts
  • corticotropin injection gel
  • insomnia and MS
  • ethnicity and MS
  • invasive cancer risk, Gilenya fingolimod

How useful was this post?

Click on a star to rate it!

Average rating 5 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Pin It on Pinterest

Share This